4.33k followers • 30 symbols Watchlist by Yahoo Finance
This list tracks the largest earnings beats for companies recently reporting earnings. This list is produced daily using the real-time earnings results reported by Selerity and limited to the top 30 stocks that meet the criteria.
A longtime Walmart greeter who has cerebral palsy is afraid he'll be out of work after store officials changed his job description to add tasks that he's physically unable to do. Adam Catlin uses a walker and is legally blind. Walmart calls Catlin a "valued member of the team" and says it's looking for a way to keep him in the store.
The lowered forecast raised questions on Wall Street about the company's ability to succeed with its $69 billion acquisition of health insurer Aetna, which closed last year. Chief Executive Larry Menlo said the proposed rule, which the Trump administration plans to put in place on Jan. 1, 2020, would force CVS to raise premiums in Medicare prescription drug plans if implemented. Menlo said in an interview that there are practical issues with implementing the proposal.
U.S. stock indexes edged mostly higher in late-afternoon trading Wednesday, on track to extend modest gains from a day earlier.
The acquisition of Aetna wasn't enough to offset continued problems for the pharmacy services giant's struggling long-term care business.
Is Trump’s Obsession with Markets an Advantage for China?(Continued from Prior Part)US-China talksUS-China trade talks have been fast-tracked as the March 2 deadline is fast approaching. A Chinese delegation is expected to visit the United States
Corp. offered a downbeat earnings projection for 2019, its first year as a merged health-care company, saying results would be dragged down by challenges in areas including its pharmacy-benefits and long-term-care businesses. The Woonsocket, R.I.-based company, which in November completed its nearly $70 billion acquisition of insurer Aetna Inc., said that it was taking rapid steps to address the problems, including a cost-cutting effort, and that its ambitious deal positioned it for long-term growth. For 2019, the company said it was projecting adjusted earnings per share of $6.68 to $6.88, compared with analysts’ estimates of $7.41 a share, as polled by Refinitiv.
LONDON (AP) — British regulators say the proposed supermarkets merger between Sainsbury's and Walmart's Asda unit would push up prices and reduce quality for shoppers, casting doubt on a deal that would create the country's biggest grocery chain.
Tech Trends: The NASDAQ, Google-Facebook Duopoly, and More(Continued from Prior Part)Walmart had a strong holiday seasonDiscount giant Walmart (WMT) reported its fiscal 2019 fourth-quarter (ended in January) results yesterday. The
The bounce has been driven mainly by growing demand for smartwatches and other wearable fitness devices that track everything from heart rates and calories to a pet's movement. The company, which competes with the likes of Fitbit Inc and TomTom, forecast full-year profit of about $3.70 per share and revenue of about $3.5 billion. Analysts were expecting profit of $3.52 per share and revenue of $3.43 billion, according to IBES data from Refinitiv.
CVS Health is setting 2019 earnings expectations well below Wall Street forecasts, as the company struggles to fix part of its business while blending in a major acquisition and attempting to change how customers use its stores. The drugstore chain and pharmacy benefit manager also is dealing with industry-wide pressure to reduce what customers pay for prescriptions. CVS Health shares sank while broader indexes stayed largely flat Wednesday after the company unveiled its 2019 forecast and detailed fourth-quarter results.
Britain's competition regulator has dealt a potentially fatal blow to Sainsbury's planned $9.5 billion takeover of Walmart's Asda, saying the supermarket groups are unlikely to be able to address its "extensive" concerns about the deal. Shares in Sainsbury's plunged as much as 17 percent on Wednesday after the Competition and Markets Authority (CMA) said its provisional view was the deal should be blocked, require the sale of a large number of stores, or even one of the brands. "Close to the worst possible outcome (for the companies)," said Bernstein analyst Bruno Monteyne.